Open AccessS146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6‐YEAR FOLLOW‐UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL
Author(s) -
Stilgenbauer S.,
Tausch E.,
Roberts A. W.,
Davids M. S.,
Eichhorst B.,
Hallek M.,
Hillmen P.,
Schneider C.,
Böttcher S.,
Popovic R.,
Ghanim M. T.,
Moran M.,
Sinai W. J.,
Wang X.,
Mukherjee N.,
Chyla B.,
Wierda W. G.,
Seymour J. F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843476.36877.79
Subject(s) - venetoclax , medicine , chronic lymphocytic leukemia , population , minimal residual disease , oncology , adverse effect , bendamustine , cohort , ighv@ , gastroenterology , leukemia , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom